NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Pilot study to evaluate efficacy, tolerance and adherence of three AR drug regimen in resource constrained rural district of Namakkal in South India.

Samuel NM; International Conference on AIDS.

Int Conf AIDS. 2002 Jul 7-12; 14: abstract no. B10593.

Tn dr Mgr Medical University, Chennai, India

BACKGROUND: HIV/AIDS is an emergency in India. Upto 5 million individuals are infected. ARV if used in public sector will assist in decrease infectiousness, OIs and will be an effective strategy to link care with prevention. OBJECTIVE: The objective of this pilot study is to evaluate the efficacy, tolerance, supervision of drug administration and adherence and monitoring issues in resource constrained settings of rural India. Patients and METHODS: Fifteen seropositive mothers who were exposed to ARV prophylaxis to reduce HIV transmission in infants are offered after extensive counselling and informed consent three AR drugs (AZT, 3TC, Neviraine). RESULTS: Clinical, virological and Immunological monitoring is undertaken before starting therapy and at three monthly intervals. CONCLUSION: All adhered to the biweekly drug supply. Preliminary results indicate that all patients tolerated well the AR drugs with no side effects. The drugs induced changes in CD4/CD8 levels and plasma HIV-1 RNA levels. This study demonstrates that three drug ARV regimen can be supervised and delivered in rural settings in India. The implications of the study go further than the benefits to the individuals influencing public health issues and care linked to prevention.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • Clinical Protocols
  • Glycoproteins
  • HIV Infections
  • Health Resources
  • Humans
  • India
  • Infant
  • Intercellular Signaling Peptides and Proteins
  • Lamivudine
  • Pharmaceutical Preparations
  • Pilot Projects
  • Zidovudine
  • amphiregulin
Other ID:
  • GWAIDS0017952
UI: 102255450

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov